Baker Tilly Wealth Management LLC Cuts Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Baker Tilly Wealth Management LLC lessened its stake in West Pharmaceutical Services, Inc. (NYSE:WST) by 74.2% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,014 shares of the medical instruments supplier’s stock after selling 2,919 shares during the quarter. Baker Tilly Wealth Management LLC’s holdings in West Pharmaceutical Services were worth $334,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the stock. Swedbank AB grew its stake in West Pharmaceutical Services by 1.6% in the 2nd quarter. Swedbank AB now owns 4,975 shares of the medical instruments supplier’s stock valued at $1,639,000 after acquiring an additional 80 shares during the last quarter. Envestnet Portfolio Solutions Inc. grew its position in shares of West Pharmaceutical Services by 0.4% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 12,554 shares of the medical instruments supplier’s stock worth $4,135,000 after buying an additional 49 shares in the last quarter. ORG Partners LLC boosted its holdings in West Pharmaceutical Services by 312.3% in the second quarter. ORG Partners LLC now owns 569 shares of the medical instruments supplier’s stock worth $185,000 after purchasing an additional 431 shares during the period. V Square Quantitative Management LLC boosted its holdings in West Pharmaceutical Services by 20.8% in the second quarter. V Square Quantitative Management LLC now owns 1,940 shares of the medical instruments supplier’s stock worth $639,000 after purchasing an additional 334 shares during the period. Finally, Diversified Trust Co boosted its holdings in West Pharmaceutical Services by 96.6% in the second quarter. Diversified Trust Co now owns 1,626 shares of the medical instruments supplier’s stock worth $536,000 after purchasing an additional 799 shares during the period. Hedge funds and other institutional investors own 93.90% of the company’s stock.

Insider Activity at West Pharmaceutical Services

In related news, SVP Silji Abraham sold 1,800 shares of West Pharmaceutical Services stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $330.78, for a total transaction of $595,404.00. Following the sale, the senior vice president now directly owns 2,860 shares in the company, valued at $946,030.80. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 0.53% of the company’s stock.

West Pharmaceutical Services Stock Performance

West Pharmaceutical Services stock traded up $7.81 during mid-day trading on Friday, reaching $300.41. The company’s stock had a trading volume of 461,491 shares, compared to its average volume of 573,045. The firm has a market cap of $21.79 billion, a price-to-earnings ratio of 39.63, a PEG ratio of 10.42 and a beta of 1.00. The business has a 50 day moving average price of $314.82 and a 200-day moving average price of $350.11. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $415.73.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.74 by ($0.22). West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The firm had revenue of $702.10 million for the quarter, compared to analyst estimates of $729.36 million. During the same period last year, the firm posted $2.11 EPS. The business’s revenue was down 6.9% compared to the same quarter last year. Sell-side analysts predict that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current fiscal year.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.